News & Updates
Filter by Specialty:
Dupilumab cuts exacerbations, improves lung function in paediatric asthma patients with high eosinophils
In the post hoc analysis of data from the phase III LIBERTY ASTHMA VOYAGE study, the monoclonal antibody dupilumab reduced exacerbations and improved lung function in children aged between 6 and 11 years with moderate-to-severe asthma and baseline blood eosinophil count of ≥500 cells/μL.
Dupilumab cuts exacerbations, improves lung function in paediatric asthma patients with high eosinophils
22 May 2023
In-utero exposure to poor air quality a risk factor for childhood ADHD
Children born to mothers who were exposed to polluted air while pregnant are at increased risk of childhood attention-deficit hyperactivity disorder (ADHD), according to a study presented at PAS 2023.
In-utero exposure to poor air quality a risk factor for childhood ADHD
20 May 2023
Topiramate, phentermine for children with obesity hold up in the real world
Treatment with phentermine, topiramate, or their combination appears to help children with severe, complicated obesity shed weight, according to real-world data.
Topiramate, phentermine for children with obesity hold up in the real world
19 May 2023
Large for gestational age tied to higher cardiometabolic risks
Individuals born large for gestational age (LGA) are more likely to develop obesity and metabolic syndrome later in life than those born appropriate for gestational age, suggests a study.